Despite this, they appear widely used in clinical practice, with CEA and CA19-9 the most often employed, and monitoring for recurrence the most common indication, but, in as many as 20% of cases, surgeons admitted to using tumor markers for diagnostic investigation. The gene discussed is CEACAM5; the disease is neoplasm.